Related by context. Frequent words. (Click for all words.) 73 relapsed refractory multiple myeloma 70 refractory multiple myeloma 69 metastatic renal cell carcinoma 68 axitinib 68 refractory PTCL 67 PXD# 67 relapsed multiple myeloma 67 placebo controlled clinical 67 IMGN# 67 diabetic neuropathic pain 66 ponatinib 66 vandetanib 66 plus prednisone 65 biologic therapy 65 HER2 positive metastatic breast 65 refractory Hodgkin lymphoma 65 azacitidine 65 tipranavir 65 dacarbazine 65 TORISEL 65 HCV genotype 1 65 Jevtana 65 phase IIa 65 SUTENT 65 tocilizumab 65 Phase 1b trial 65 tanespimycin 64 castration resistant prostate cancer 64 vicriviroc 64 decitabine 64 dose cohorts 64 sunitinib 64 PegIntron 64 peginterferon 64 valopicitabine 64 ofatumumab 64 nab paclitaxel 64 Taxotere ® 64 romidepsin 64 chronic HCV infection 64 peginterferon alfa 2a 64 HGS ETR1 64 HCV infected 64 Phase 2a trial 64 therapeutic regimens 64 lupus nephritis 63 CR# vcMMAE 63 double blinded placebo 63 REMICADE ® 63 evaluable patients 63 plus ribavirin 63 dasatinib 63 active comparator 63 phase IIb 63 REVLIMID ® 63 nitazoxanide 63 Solid Tumors 63 PROMACTA 63 Phenoptin 63 temsirolimus 63 Phase 2b trial 63 neoadjuvant 63 Torisel 63 BAY #-# 63 SCH # 63 Phase 1b clinical 63 nilotinib 63 relapsed refractory 63 lymphoma CTCL 63 relapsing remitting multiple sclerosis 63 dose escalation trial 62 T2DM 62 Phase Ib 62 Phase 2b study 62 allogeneic stem cell 62 TREANDA 62 Phase IIa trial 62 ocrelizumab 62 HuMax CD# 62 peg IFN 62 medullary thyroid cancer 62 alvimopan 62 interferon alfa 62 sorafenib 62 chronic HCV 62 FOLFIRI 62 registrational 62 vinorelbine 62 virologic failure 62 Pivotal Phase III 62 malignant pleural mesothelioma 62 Phase 1b 62 stable angina 62 abiraterone 62 hematological cancers 62 IMC A# 62 advanced NSCLC 62 Azedra 61 methylnaltrexone 61 fludarabine 61 HRPC